Endotherapy Devices

Global Endotherapy Devices Market to Reach US$7.1 Billion by 2030

The global market for Endotherapy Devices estimated at US$5.0 Billion in the year 2024, is expected to reach US$7.1 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Gastrointestinal devices & accessories, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Endoscopic retrograde cholangio pancreatography devices & accessories segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 9.0% CAGR

The Endotherapy Devices market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Endotherapy Devices Market – Key Trends & Drivers Summarized

What Is Driving the Strategic Importance of Endotherapy Devices in Modern Healthcare?
The endotherapy devices market has emerged as one of the most strategically important components of the endoscopy landscape, propelled by the rapid transformation of endoscopy from a diagnostic tool to a therapeutic platform. These devices, including snares, stents, hemostatic clips, dilation balloons, retrieval baskets, electrosurgical tools, and ablation systems, are instrumental in enabling minimally invasive treatment of gastrointestinal, pulmonary, urological, and biliary disorders. Their application spans a wide clinical spectrum — from polypectomy and gastrointestinal bleeding management to endoscopic stricturoplasty and tumor resection — allowing patients to avoid more invasive surgical alternatives. As minimally invasive interventions gain ground globally, endotherapy devices are playing an increasingly central role in expanding procedural capabilities and enabling same-day therapeutic care across high-volume centers and ambulatory surgical facilities.

The rising burden of chronic GI conditions, such as colorectal cancer, inflammatory bowel disease (IBD), and GERD, alongside the growing prevalence of obesity-related disorders, has amplified the need for advanced endoscopic therapeutic solutions. Endotherapy is now considered a front-line option in managing early-stage cancers, functional GI disorders, and biliary obstructions, especially in patients unsuitable for open surgery. These devices are being adopted across diverse care settings, from tertiary hospitals and academic centers to standalone GI clinics. As health systems push for shorter hospital stays, reduced complications, and faster recovery times, the demand for versatile, high-efficacy endotherapy solutions is accelerating globally — with market expansion reinforced by reimbursement coverage improvements, increased procedural training, and better integration of these devices into value-based care models.

How Are Technological Advancements Enhancing Therapeutic Precision and Outcomes?
The evolution of endotherapy devices is tightly interwoven with advancements in material science, design innovation, and energy delivery technologies. Manufacturers are introducing devices with improved maneuverability, reduced profile diameters, and enhanced precision to navigate complex anatomies and enable tissue-specific intervention. Electrosurgical knives and ablation catheters are now engineered with insulation controls, smart energy feedback systems, and multi-functional tips to allow coagulation, dissection, and resection in a single tool. These advancements are not only reducing procedure time but also minimizing risk and improving reproducibility across varying skill levels.

Smart therapeutic systems are also gaining traction. Examples include self-expanding stents with anti-migration features, drug-eluting variants for oncology applications, and balloon catheters with integrated sensors to regulate pressure and temperature. Advanced retrieval devices, like rotatable baskets and magnetic probes, are facilitating safer foreign body extraction and stent removal. The convergence of endotherapy with digital endoscopy and AI-assisted navigation systems is enabling more precise localization and deployment of devices. Moreover, the integration of disposable and semi-disposable therapeutic tools is improving infection control and procedural efficiency — a factor of growing importance in ambulatory and outpatient care settings. As new endoscopic techniques such as ESD, POEM, and NOTES mature, the sophistication and specificity of the endotherapy tools designed to support them continue to advance, reshaping the boundaries of what can be achieved through flexible endoscopy.

Which Clinical Areas and Applications Are Fueling Market Expansion?
The widespread applicability of endotherapy devices across multiple disciplines is a core engine of market growth. In gastroenterology, where these tools are most heavily used, high-volume procedures such as polypectomies, gastrointestinal bleeding control, and stent placements for malignant or benign strictures are driving daily utilization. With the increasing adoption of colorectal cancer screening programs worldwide, demand for snare-based polypectomy and endoscopic mucosal resection (EMR) kits has surged. Similarly, the growth in bariatric endoscopy has introduced a new set of requirements for tissue approximation tools, suturing systems, and closure devices. Electrosurgical solutions are also gaining favor in managing conditions such as Barrett’s esophagus through radiofrequency ablation or cryotherapy-assisted procedures.

Beyond GI, urology and pulmonology are emerging as high-growth areas for endotherapy device adoption. Urologists are using balloon dilation and self-expanding metallic stents (SEMS) for managing urethral strictures and urinary tract obstructions, while pulmonologists are increasingly using stents, forceps, and retrieval devices in interventional bronchoscopy. Biliary endoscopy, particularly in ERCP procedures, is experiencing a surge in demand for retrieval baskets, dilation balloons, and wire-guided cannulation accessories. Meanwhile, the shift toward day-case procedures is reinforcing demand for single-use, easy-to-deploy tools that can support fast turnover without compromising safety. The expansion of procedural scope in both established and emerging specialties is enabling device manufacturers to capture diversified revenue streams and position their products across multiple clinical endpoints.

What Are the Core Drivers Accelerating Global Market Growth Today?
The growth in the endotherapy devices market is driven by several factors centered on technological evolution, expanding end-use applications, and procedural migration toward minimally invasive therapeutic endoscopy. Technological innovations such as multi-functional electrosurgical tools, drug-eluting and self-expanding stents, advanced hemostatic agents, and sensor-embedded dilation balloons are enabling more complex interventions to be performed endoscopically. These innovations are expanding the procedural envelope and supporting safer, more efficient treatment across a broader patient base.

End-use diversification is another major driver, as demand increases across gastroenterology, pulmonology, urology, and bariatrics. Each specialty presents unique anatomical and procedural challenges, necessitating the development of customized toolsets tailored to specific disease conditions and surgical objectives. In parallel, the rise of outpatient endoscopy centers, ambulatory surgical facilities, and specialty GI clinics is creating new demand for portable, sterile, and single-use therapeutic tools. Procedural growth is also being accelerated by healthcare infrastructure investments in Asia-Pacific, the Middle East, and Latin America, where public and private sector partnerships are equipping hospitals with advanced endoscopy capabilities. In mature markets, reimbursement reforms and value-based care incentives are aligning with trends in early diagnosis and intervention, reinforcing the commercial case for endotherapy device adoption. These factors collectively position the market for sustained global growth — supported by continued innovation, clinical expansion, and cross-specialty integration.

SCOPE OF STUDY:

The report analyzes the Endotherapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Gastrointestinal devices & accessories, Endoscopic retrograde cholangio pancreatography devices & accessories, Other products); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• B. Braun Melsungen AG
• Boston Scientific Corporation
• CONMED Corporation
• Cook Medical
• Ethicon Endo-Surgery (Johnson & Johnson)
• Fujifilm Holdings Corporation
• HOYA Corporation
• Intuitive Surgical
• KARL STORZ SE & Co. KG
• M.I. Tech Co Ltd
• Medtronic plc
• Micro-Tech (Nanjing) Co Ltd
• Olympus Corporation
• Richard Wolf GmbH
• Smith & Nephew plc
• Steris Corporation
• Stryker Corporation
• Taewoong Medical Co., Ltd
• Vimex Sp. z o.o.
• WISAP Medical Technology GmbH

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.